Ruxolitinib in refractory acute and chronic graft-versus-host disease: a multicenter survey study

Graft-versus-host disease is the main cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation. First-line treatment is based on the use of high doses of corticosteroids. Unfortunately, second-line treatment for both acute and chronic graft-versus-host disease, remai...

Descripción completa

Detalles Bibliográficos
Autores principales: Escamilla Gómez, Virginia, García-Gutiérrez, Valentín, López Corral, Lucía, García Cadenas, Irene, Pérez Martínez, Ariadna, Márquez Malaver, Francisco J., Caballero-Velázquez, Teresa, González Sierra, Pedro A., Viguria Alegría, María C., Parra Salinas, Ingrid M., Calderón Cabrera, Cristina, González Vicent, Marta, Rodríguez Torres, Nancy, Parody Porras, Rocío, Ferra Coll, Christelle, Orti, Guillermo, Valcárcel Ferreiras, David, De la Cámara LLanzá, Rafael, Molés, Paula, Velázquez-Kennedy, Kyra, João Mende, María, Caballero Barrigón, Dolores, Pérez, Estefanía, Martino Bofarull, Rodrigo, Saavedra Gerosa, Silvanna, Sierra, Jorge, Poch, Marc, Zudaire Ripa, María T., Díaz Pérez, Miguel A., Molina Angulo, Blanca, Sánchez Ortega, Isabel, Sanz Caballer, Jaime, Montoro Gómez, Juan, Espigado Tocino, Ildefonso, Pérez-Simón, José A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7051903/
https://www.ncbi.nlm.nih.gov/pubmed/31700138
http://dx.doi.org/10.1038/s41409-019-0731-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7051903/
https://www.ncbi.nlm.nih.gov/pubmed/31700138
http://dx.doi.org/10.1038/s41409-019-0731-x

Ejemplares similares